Expert Opinion on Therapeutic Targets

Nuclear factor-κB: a transcription factor for all seasons
pp. 109-110(2)
Author: Aggarwal, Bharat B

NF-κB as a therapeutic target in autoimmune disease
pp. 111-122(12)
Authors: O'Sullivan, Brendan; Thompson, Angus; Thomas, Ranjeny

NF-κB as a therapeutic target in neurodegenerative diseases
pp. 123-132(10)
Authors: Camandola, Simonetta; Mattson, Mark P

NF-κB as a target for cancer therapy
pp. 133-144(12)
Authors: Melisi, Davide; Chiao, Paul J

Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs
pp. 145-159(15)
Authors: Noble, Florence; Roques, Bernard P

Targeting acetylcholinesterase to treat neurodegeneration
pp. 161-179(19)
Authors: Holzgrabe, Ulrike; Kapková, Petra; Alptüzün, Vildan; Scheiber, Josef; Kugelmann, Eva

MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?
pp. 181-189(9)
Authors: Burnett, John R; Watts, Gerald F

The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
pp. 191-205(15)
Authors: Karagiannis, Asterios; Mikhailidis, Dimitri P; Athyros, Vasilios G; Kakafika, Anna I; Tziomalos, Konstantinos; Liberopoulos, Evangelos N; Florentin, Matilda; Elisaf, Moses

Malignancies of the head and neck: the role for molecular targeted agents
pp. 207-217(11)
Author: Agulnik, Mark

Is YKL-40 a new therapeutic target in cancer?
pp. 219-234(16)
Authors: Johansen, Julia S; Jensen, Benny Vittrup; Roslind, Anne; Price, Paul A

Targeting serum antibody for cancer diagnosis: a focus on colorectal cancer
pp. 235-244(10)
Authors: Lu, Hailing; Goodell, Vivian; Disis, Mary L

Recent advances in targeted therapy for non-small cell lung cancer
pp. 245-257(13)
Authors: Ramalingam, Suresh; Belani, Chandra P

Corrigendum
pp. 263-263(1)